Market revenue in 2023 | USD 6,936.9 million |
Market revenue in 2030 | USD 10,360.0 million |
Growth rate | 5.9% (CAGR from 2023 to 2030) |
Largest segment | Synthetic |
Fastest growing segment | Biotech |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Synthetic, Biotech |
Key market players worldwide | Basf SE, CordenPharma, Bristol-Myers Squibb Co, Pfizer Inc, Boehringer Ingelheim Pharma, Dr. Reddy’s Laboratories, Sun Pharmaceutical Industries, Albany Molecular Research, Sanofi SA, Lonza Group Ltd, Cipla Ltd DR, Merck & Co Inc, Teva Pharmaceutical Industries Ltd, Novartis AG ADR, Roche Holding AG |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to high potency active pharmaceutical ingredients market will help companies and investors design strategic landscapes.
Synthetic was the largest segment with a revenue share of 72.14% in 2023. Horizon Databook has segmented the Europe high potency active pharmaceutical ingredients market based on synthetic, biotech covering the revenue growth of each sub-segment from 2018 to 2030.
Increase in research funding and local presence of key market players in this region are expected to drive the market. The number of biopharmaceutical companies is growing in Europe owing to increasing investments.
For instance, in 2017, USD 20 billion was raised as investment by biopharma industry, which increased by 28% to USD 27.5 billion in 2019. Moreover, key players conduct their biopharmaceutical R&D in Europe. Europe is the second-largest market for HPAPI, in terms of revenue share, and is expected to remain unaltered till 2027.
This can be attributed to the presence of developed economies, such as Germany, Turkey, the UK, France, and Italy, in the region. Availability of advanced technology and increasing R&D in Europe are anticipated to fuel the market growth during the forecast period.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe high potency active pharmaceutical ingredients market , including forecasts for subscribers. This continent databook contains high-level insights into Europe high potency active pharmaceutical ingredients market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account